Milenko Cicmil
InvestorPartner at Cure Ventures
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Associated with portfolio company Tasca Therapeutics, which works on post-translational modification to expand the druggable proteome.
Experience
- University of ReadingVisiting Research Fellow at Univ. of Reading, UKcurrent2020 — presentUnited Kingdom
- Cure VenturesPartnercurrent2021 — presentUnited States
- AMP DiscoveryChairman Of The Board AMP Discovery2021 — 2022
- IpsenVice President Global Head of external Innovation2019 — 2021Cambridge, Massachusetts, USA
- FogPharmaVice President - Translational Biology2017 — 2019Cambridge, USA
- MerckDirector at Merck Innovation Hub2016 — 2017Cambridge USA
- MerckDirector Pharmacology Immuno-Oncology and Immunomodulation2013 — 2016Greater Boston Area
- MerckDirector In vivo Pharmacology R&I2011 — 2013Boston, US
- AstraZenecaGroup Leader Integrative Pharmacology Discovery Bioscience - Inflammation2007 — 2011Leicester, United Kingdom
- AstraZenecaSenior Research Scientist2004 — 2007Leicester, United Kingdom
- GE HealthcareSenior Research Scientist2002 — 2004Amersham UK
- Cancer Research UKTranslational Science - Research Fellow2000 — 2002London, United Kingdom
Skills & more
Biochemistry5Biomarker Discovery7Biomarkers7Biotechnology5CRO3Cell Culture3Clinical Development6DMPK2Drug Design4Drug Development14Drug Discovery25In Vitro7
+6 more
In VivoLead ChangeLifesciencesPharmaceutical IndustryPharmacologyTarget IdentificationFrom Milenko's professional profile.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Frequently asked questions
- Who is Milenko Cicmil?
- Associated with portfolio company Tasca Therapeutics, which works on post-translational modification to expand the druggable proteome.
- Where does Milenko Cicmil work?
- Milenko Cicmil is Partner at Cure Ventures.
- What check size does Milenko Cicmil write?
- Milenko Cicmil typically writes checks of $100K – $5M.
- Where did Milenko Cicmil go to school?
- Milenko Cicmil studied at King's College London (Bachelor’s Degree, Cell/Cellular and Molecular Biology); University of Reading (Doctor of Philosophy (Ph.D.), Molecular Pharmacology).
Same school
Also attended King's College London279
Harry StebbingsFounder & General Partner at 20VCDominic JacquessonInvestor at Index VenturesJohn HortonInvestor at DN CapitalBob ThomasPartner at OxxKatherineHealthcare Investment Lead at Hummingbird VenturesÖzge Gizem YerlikayaGeneral Counsel at Idacapital
+ 273 more
Also attended University of Reading75
Ziad Al-TunisiBoard of Directors (Chairman) at Nuwa CapitalTony CorbinGeneral Partner & Chief Financial Officer at White Star CapitalRobert Whitby-SmithInvestor at AlbionVCJulie DaviesFund Accountant at Future Planet CapitalJordan OngInvestment Associate at Future Planet CapitalPierce PolakSenior Associate at Fuel Ventures
+ 69 more
Shared employers
Also worked at Ipsen11
Awny FarajallahChief Medical Officer at Takeda VenturesPierce PolakSenior Associate at Fuel VenturesSarah ShackeltonAdvisor at Delin VenturesRenaud GuillermFounder at SIDE-CapitalClement SalqueAssociate at Bioqube VenturesRachel SchillingConsulting at Rock Health
+ 5 more
Also worked at FogPharma4
Also worked at Merck128
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesAndrea van ElsasInvestor at Third Rock Ventures
+ 122 more
Also worked at AstraZeneca69
Detlev BiniszkiewiczManaging Director at MPM BioImpactBriggs MorrisonEntrepreneur Partner at MPM BioImpactJung Lee, PhDVenture Partner at Adelphi Ventures Management, LlcJohan LundVenture Partner at ScietyIliam BarkinoInvestor at IndustrifondenSara JawadInvestor at Industrifonden
+ 63 more


















.avif)

























